Compare GOAI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOAI | RPID |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 84.8M |
| IPO Year | 2023 | 2021 |
| Metric | GOAI | RPID |
|---|---|---|
| Price | $1.79 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 181.6K | ★ 307.6K |
| Earning Date | 04-10-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | $17,037,328.00 | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 82.59 | 19.74 |
| 52 Week Low | $1.42 | $1.08 |
| 52 Week High | $6.67 | $4.94 |
| Indicator | GOAI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 25.73 |
| Support Level | $1.62 | N/A |
| Resistance Level | $2.66 | $2.18 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 3.77 | 16.67 |
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.